Abstract:Significance: Reactive oxygen species (ROS) are generated during mitochondrial oxidative metabolism, and are tightly controlled through homeostatic mechanisms to maintain intracellular redox, regulating growth and proliferation in healthy cells. However, ROS production is perturbed in cancers where abnormal accumulation of ROS leads to oxidative stress and genomic instability, triggering oncogenic signaling pathways on one hand, while increasing oxidative damage and triggering ROS-dependent death signaling on the other. Recent Advances: Our review illuminates how critical interactions between ROS and oncogenic signaling, the tumor microenvironment, and DNA damage response (DDR) pathways have led to interest in ROS modulation as a means of enhancing existing anticancer strategies and developing new therapeutic opportunities. Critical Issues: ROS equilibrium exists via a delicate balance of pro-oxidant and antioxidant species within cells. "Antioxidant" approaches have been explored mainly in the form of chemoprevention, but there is insufficient evidence to advocate its routine application. More progress has been made via the "pro-oxidant" approach of targeting cancer vulnerabilities and inducing oxidative stress. Various therapeutic modalities have employed this approach, including direct ROS-inducing agents, chemotherapy, targeted therapies, DDR therapies, radiotherapy, and immunotherapy. Finally, emerging delivery systems such as "nanosensitizers" as radiotherapy enhancers are currently in development. Future Directions: While approaches designed to induce ROS have shown considerable promise in selectively targeting cancer cells and dealing with resistance to conventional therapies, most are still in early phases of development and challenges remain. Further research should endeavor to refine treatment strategies, optimize drug combinations, and identify predictive biomarkers of ROS-based cancer therapies.

The role of cellular reactive oxygen species in cancer chemotherapy

Oxidative Stress Response Induced by Chemotherapy in Leukemia Treatment (Review)

Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies

Targeting ROS in cancer: rationale and strategies

Induction of Reactive Oxygen Species: an Emerging Approach for Cancer Therapy

Targeting the Redox Landscape in Cancer Therapy

Targeting Metabolic-Redox Circuits for Cancer Therapy

Models of Reactive Oxygen Species in Cancer

The double-edged roles of ROS in cancer prevention and therapy

Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy

Metabolic Regulation of Redox Balance in Cancer

Modulation of reactive oxygen species in cancers: recent advances

Cancer Metabolism: The Role of ROS in DNA Damage and Induction of Apoptosis in Cancer Cells

Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements

Reactive Oxygen Species and Colorectal Cancer

Reactive oxygen species-upregulating nanomedicines towards enhanced cancer therapy

Roles of Reactive Oxygen Species in Inflammation and Cancer

Redox Dysregulation in the Tumor Microenvironment Contributes to Cancer Metastasis.

Redox regulation and its emerging roles in cancer treatment

Teaching the basics of reactive oxygen species and their relevance to cancer biology: Mitochondrial reactive oxygen species detection, redox signaling, and targeted therapies

Modulating ROS to Overcome Multidrug Resistance in Cancer.